Bacille Calmette-Guérin Vaccine Strain Modulates the Ontogeny of Both Mycobacterial-Specific and Heterologous T Cell Immunity to Vaccination in Infants by Agano Kiravu, Sophia Osawe, Anna-Ursula Happel, Trishana Nundalall, Jerome Wendoh, Sophie Beer, Nobomi Dontsa, Olatogni Berenice Alinde, Sikiratu Mohammed, Pam Datong, D. William Cameron, Kenneth Rosenthal, Alash'le Abimiku, Alash'le Abimiku, Heather B. Jaspan, Heather B. Jaspan, Clive M. Gray, Clive M. Gray

“…These findings have implications for vaccine policy makers, manufacturers and programs worldwide and also suggest that BCG-Denmark, the first vaccine received in many African infants, has both specific and off-target effects in the first few months of life, which may provide an immune priming benefit to other EPI vaccines.…”
Get full text

Incidence and risk factors of herpes zoster in human immunodeficiency virus-positive patients initiating combination antiretroviral therapy in Taiwan by Yi-Chieh Lee, Chien-Ching Hung, Mao-Song Tsai, Jun-Yu Zhang, Pei-Ying Wu, Shang-Ping Yang, Yu-Zhen Luo, Hsi-Yen Chang, Wen-Chun Liu, Hsin-Yun Sun, Shan-Chwen Chang

“…Background/Purpose: To obtain current epidemiological data for better vaccination policies, this study aimed to assess the incidence and risk factors of herpes zoster in human immunodeficiency virus (HIV)-positive patients initiating combination antiretroviral therapy (cART) in Taiwan. …”
Get full text

FRONTLINE NURSES’ INTENTION TO RECEIVE A COVID-19 VACCINE BOOSTER: DOES AN EFFECTIVE ORGANISATIONAL COMMUNICATION RELATIONSHIP MATTERS by E.L.-Y. Wong, A.W.-L. Cheung, A.Y.-K. Wong, T.K.-S. Sun, C.H.-K. Yam, H.-Y. Miao, M.C.-Y. Wong, E.-K. Yeoh

“…Conclusion: It highlights the important of effective communication on its effectiveness of COVID-19 vaccine policy within healthcare settings in HK.…”
Get full text

Dialysis Patients Respond Adequately to Influenza Vaccination Irrespective of Dialysis Modality and Chronic Inflammation by Christos Pleros, Konstantinos Adamidis, Konstantia Kantartzi, Ioannis Griveas, Ismini Baltsavia, Aristides Moustakas, Antonios Kalliaropoulos, Evaggelia Fraggedaki, Christina Petra, Nikolaos Damianakis, Andreas Mentis, Eleni Drosataki, Ioannis Petrakis, Ploumis Passadakis, Periklis Panagopoulos, Kostas Stylianou, Stylianos Panagoutsos

“…IL-6 levels significantly differed between study groups, with HD patients displaying the highest values, but this did not affect SP rates. (4) Conclusions: Dialysis patients respond to influenza immunization adequately and similarly to the general population. Thus, annual vaccination policies should be encouraged in dialysis units. …”
Get full text

Knowledge, Attitudes, Perceptions and Vaccination Acceptance/Hesitancy among the Community Pharmacists of Palermo’s Province, Italy: From Influenza to COVID-19 by Claudio Costantino, Giorgio Graziano, Nicole Bonaccorso, Arianna Conforto, Livia Cimino, Martina Sciortino, Francesco Scarpitta, Chiara Giuffrè, Salvatore Mannino, Mario Bilardo, Caterina Ledda, Francesco Vitale, Vincenzo Restivo, Walter Mazzucco

“…The achievement of very high COVID-19 vaccination coverage rates among healthcare professionals (HCPs) in the present study was mainly due to the mandatory vaccination policies; nevertheless, a willingness for COVID-19 vaccination was relatively high among pharmacists before the beginning of the vaccination campaign. …”
Get full text

Could BCG Vaccination Indeed Have a Key Role for Reducing the Spread and Mortality of COVID-19 Worldwide? by İlke Özer Aslan, Öner Özdemir, Mustafa Törehan Aslan

“…The countries such as Italy, Holland and USA applying non-universal BCG vaccination policies, it is noteworthy that COVID-19 progresses more severely, compared to the countries following the universal policy. …”
Get full text

Systematic review of the effect of additional doses of oral rotavirus vaccine on immunogenicity and reduction in diarrhoeal disease among young children by Bianca F. Middleton, Parveen Fathima, Thomas L. Snelling, Peter Morris

“…Evidence of an impact on diarrhoeal disease is needed before additional dose rotavirus vaccine schedules can be recommended as vaccine policy. Funding: BM was funded by the National Health and Medical Research Council, the Royal Australasian College of Physicians Paediatrics and Child Health Division, and the Australian Academy of Science.…”
Get full text

Delivering COVID-19 vaccine trials at speed: the implementation of a phase IV UK multi-centre randomised controlled trial to determine safety and immunogenicity of COVID-19 vaccine... by Sarah Baos, Rachel Todd, Russell Thirard, Rosie Harris, Jana Kirwan, Katherine Joyce, David Hutton, Adam Finn, Madeleine Clout, Heike Cappel-Porter, Chris A Rogers, Rajeka Lazarus, Lucy Culliford

“…Abstract Background In February 2021, the UK Department of Health and Social Care sought evidence on the safety and immunogenicity of COVID-19 and influenza vaccine co-administration to inform the 2021/2022 influenza vaccine policy. Co-administration could support vaccine uptake and reduce healthcare appointments. …”
Get full text

Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1 by Galles, NC, Liu, PY, Updike, RL, Moore, CE

“…<p><strong>Background</strong></p> Measuring routine childhood vaccination is crucial to inform global vaccine policies and programme implementation, and to track progress towards targets set by the Global Vaccine Action Plan (GVAP) and Immunization Agenda 2030. …”

CD4+ and CD8+ T cells and antibodies are associated with protection against Delta vaccine breakthrough infection: a nested case-control study within the PITCH study by Isabel Neale, Mohammad Ali, Barbara Kronsteiner, Stephanie Longet, Priyanka Abraham, Alexandra S. Deeks, Anthony Brown, Shona C. Moore, Lizzie Stafford, Susan L. Dobson, Megan Plowright, Thomas A. H. Newman, Mary Y. Wu, Edward J. Carr, Rupert Beale, Ashley D. Otter, Susan Hopkins, Victoria Hall, Adriana Tomic, Rebecca P. Payne, Eleanor Barnes, Alex Richter, Christopher J. A. Duncan, Lance Turtle, Thushan I. de Silva, Miles Carroll, Teresa Lambe, Paul Klenerman, Susanna Dunachie

“…IMPORTANCE Defining correlates of protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine breakthrough infection informs vaccine policy for booster doses and future vaccine designs. …”
Get full text

Modelling the Cost-Effectiveness of Hepatitis A in South Africa by Jenna Patterson, Susan Cleary, Jared Michael Norman, Heiletjé Van Zyl, Timothy Awine, Saadiyah Mayet, Benjamin Kagina, Rudzani Muloiwa, Gregory Hussey, Sheetal Prakash Silal

“…The modelling presented in this paper has been used to develop a user-friendly application for vaccine policy makers to further interrogate the model outcomes and consider the costs and benefits of introducing routine hepatitis A vaccination in South Africa.…”
Get full text

Perception and Mental Health Status Regarding COVID-19 Vaccination Among Taiwanese Adolescents and Their Caregivers by Hwang JW, Chien SJ, Wang CC, Kuo KC, Tang KS, Lee Y, Chen YC, Lo MH, Lee IK, Chuah SK, Lee CT, Kung CT, Wang LJ

“…These findings can serve as crucial references for healthcare providers and governments when formulating vaccination policies for adolescents in the future.Keywords: adolescent, autonomy, caregivers, vaccine, psychosomatic, SARS-Cov-2…”
Get full text

Durability of the Effectiveness of Heterologous COVID-19 Vaccine Regimens in Thailand: Retrospective Cohort Study Using National Registration Data by Ponlagrit Kumwichar, Chittawan Poonsiri, Siobhan Botwright, Natchalaikorn Sirichumroonwit, Bootsakorn Loharjun, Supharerk Thawillarp, Nontawit Cheewaruangroj, Amorn Chokchaisiripakdee, Yot Teerawattananon, Virasakdi Chongsuvivatwong

“… BackgroundThe durability of heterologous COVID-19 vaccine effectiveness (VE) has been primarily studied in high-income countries, while evaluation of heterologous vaccine policies in low- and middle-income countries remains limited. …”
Get full text

First dose ChAdOx1 and BNT162b2 COVID-19 vaccinations and cerebral venous sinus thrombosis: A pooled self-controlled case series study of 11.6 million individuals in England, Scotl... by Steven Kerr, Mark Joy, Fatemeh Torabi, Stuart Bedston, Ashley Akbari, Utkarsh Agrawal, Jillian Beggs, Declan Bradley, Antony Chuter, Annemarie B Docherty, David Ford, Richard Hobbs, Srinivasa Vittal Katikireddi, Emily Lowthian, Simon de Lusignan, Ronan Lyons, James Marple, Colin McCowan, Dylan McGagh, Jim McMenamin, Emily Moore, Josephine-L K Murray, Rhiannon K Owen, Jiafeng Pan, Lewis Ritchie, Syed Ahmar Shah, Ting Shi, Sarah Stock, Ruby S M Tsang, Eleftheria Vasileiou, Mark Woolhouse, Colin R Simpson, Chris Robertson, Aziz Sheikh

“…This evidence may be useful in risk-benefit analyses of vaccine policies and in providing quantification of risks associated with vaccination to the general public.…”
Get full text

COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort study by Agrawal, U, Katikireddi, SV, McCowan, C, Mulholland, RH, Azcoaga-Lorenzo, A, Amele, S, Fagbamigbe, AF, Vasileiou, E, Grange, Z, Shi, T, Kerr, S, Moore, E, Murray, JLK, Shah, SA, Ritchie, L, O'Reilly, D, Stock, SJ, Beggs, J, Chuter, A, Torabi, F, Akbari, A, Bedston, S, McMenamin, J, Wood, R, Tang, RSM, de Lusignan, S, Hobbs, FDR, Woolhouse, M, Simpson, CR, Robertson, C, Sheikh, A

“…Sociodemographic and clinical features known to increase the risk of severe disease in unvaccinated populations were also associated with severe outcomes in people receiving their first dose of vaccine and could help inform case management and future vaccine policy formulation. …”

First dose ChAdOx1 and BNT162b2 COVID-19 vaccinations and cerebral venous sinus thrombosis: a pooled self-controlled case series study of 11.6 million individuals in England, Scotl... by Kerr, S, Joy, M, Torabi, F, Bedston, S, Akbari, A, Agrawal, U, Beggs, J, Bradley, D, Chuter, A, Docherty, AB, Ford, D, Hobbs, R, Katikireddi, SV, Lowthian, E, de Lusignan, S, Lyons, R, Marple, J, McCowan, C, McGagh, D, McMenamin, J, Moore, E, Murray, J-LK, Owen, RK, Pan, J, Ritchie, L, Shah, SA, Shi, T, Stock, S, Tsang, RSM, Vasileiou, E, Woolhouse, M, Simpson, CR, Robertson, C, Sheikh, A

“…This evidence may be useful in risk–benefit analyses of vaccine policies and in providing quantification of risks associated with vaccination to the general public.…”

Analysis on the intention and influencing factors of free influenza vaccination among the elderly people aged 70 and above in Hangzhou in 2022 by Xinren Che, Yan Liu, Wenwen Gu, Fangying Wang, Jun Wang, Wei Jiang, Jian Du, Xiaoping Zhang, Yuyang Xu, Xuechao Zhang, Jing Wang

“…ORcentralurbanarea = 2.218, 95%CI: 1.626 3.027), and convenient for movement (hesitancy: ORyes = 0.494, 95%CI: 0.420 0.580, Unwilling: ORyes = 0.585, 95%CI: 0.480 0.713), understanding of the free vaccine policy (hesitancy: ORunderstand = 0.204, 95%CI: 0.171 0.245, Unwilling: ORunderstand = 0.164, 95%CI: 0.128 0.210), influenza knowledge level≥ 13 points (hesitancy: OR≥13points = 0.628, 95%CI: 0.533 0.739, Unwilling: OR≥13points = 0.538, 95%CI: 0.437 0.662), influenza vaccine knowledge level≥ 12 points (hesitancy: OR≥12points = 0.422, 95%CI: 0.350 0.508, Unwilling: OR≥12points = 0.370, 95%CI: 0.290 0.472), and social trust level ≥ 12 points (hesitancy: OR≥12points = 0.134, 95%CI: 0.112 0.160, Unwilling: OR≥12points = 0.220, 95%CI: 0.180 0.269) are more willing to receive free influenza vaccine.ConclusionThe proportion of elderly people aged 70 and above who are willing to receive free influenza vaccine is high in Hangzhou. …”
Get full text

The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study by Allison Portnoy, Rebecca A. Clark, Matthew Quaife, Chathika K. Weerasuriya, Christinah Mukandavire, Roel Bakker, Arminder K. Deol, Shelly Malhotra, Nebiat Gebreselassie, Matteo Zignol, So Yoon Sim, Raymond C. W. Hutubessy, Inés Garcia Baena, Nobuyuki Nishikiori, Mark Jit, Richard G. White, Nicolas A. Menzies

“…The results of these analyses can be used by global and country stakeholders to inform TB vaccine policy and introduction preparedness, as well as decision-making around future development, adoption, and implementation of novel TB vaccines.…”
Get full text